美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

上海醫藥ADR

7.07

0.0000

成交量：- -

成交額：- -

市值：52.38億

市盈率：8.77

高：7.07

開：7.07

低：7.07

收：7.07

52周最高：8.32

52周最低：6.39

股本：7.41億

流通股本：3.65億

量比：0.11

換手率：- -

股息：0.30

股息率：4.21%

每股收益(TTM):0.8063

每股收益(LYR):0.8419

淨資產收益率：7.91%

總資產收益率：2.15%

市淨率：0.48

市盈率(LYR):8.40

資料載入中...

總覽公司新聞資訊公告

概念

no data

沒有相關數據

資金流向

資金流入：

資金流出：

新聞資訊

上海市經信委：在上海好模型不缺算力，好應用不缺語料，好產品不缺芯片

上海醫藥：芪苓顆粒獲得臨牀試驗批准通知書

格隆汇资讯

上海醫藥B023細胞注射液臨牀試驗獲批

中信建投：腦機接口有望打開萬億市場空間需發掘國家政策支持和具有真實需求「真腦機」

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/SHPMY"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"SHPMY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPMY\",,,,,undefined,":{"symbol":"SHPMY","market":"US","secType":"STK","nameCN":"上海醫藥ADR","latestPrice":7.07,"timestamp":1771016400000,"preClose":7.07,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":365061763,"shares":740922171,"eps":0.806273,"marketStatus":"總統日休市","change":0,"latestTime":"02-13 16:00:00 EST 延時","open":7.07,"high":7.07,"low":7.07,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.806273,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1771318800000},"marketStatusCode":7,"adr":0,"adrRate":5,"exchange":"PINK LIMITED","adjPreClose":7.07,"volumeRatio":0.10582018980438346},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SHPMY\",,,,,undefined,":{"symbol":"SHPMY","floatShares":365061763,"roa":"2.15%","roe":"7.91%","lyrEps":0.841928,"volumeRatio":0.10582018980438346,"shares":740922171,"dividePrice":0.297601,"high":7.07,"amplitude":0,"preClose":7.07,"low":7.07,"week52Low":6.39,"pbRate":"0.48","psRate":"0.13","week52High":8.32,"institutionHeld":0,"latestPrice":7.07,"eps":0.806273,"divideRate":0.042093,"volume":0,"delay":15,"ttmEps":0.806273,"open":7.07,"prevYearClose":8.23,"prevWeekClose":7.07,"prevMonthClose":8.23,"prevQuarterClose":8.23,"fiveDayClose":7.97,"twentyDayClose":8.23,"sixtyDayClose":8.23},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SHPMY\",params:#limit:5,,,undefined,":[{"date":"2025-12-31","symbol":"SHPMY","amount":0.084937,"announcedDate":"2025-12-10","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-31","defaultRemindTime":1767191400000,"name":"上海医药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-02-23","payableDate":"2025-12-31","currency":"USD","dateTimestamp":1767157200000,"payDate":"2026-02-23"},{"date":"2025-07-17","symbol":"SHPMY","amount":0.202369,"announcedDate":"2025-06-30","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-07-17","defaultRemindTime":1752759000000,"name":"上海医药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-09","payableDate":"2025-07-17","currency":"USD","dateTimestamp":1752724800000,"payDate":"2025-09-09"},{"market":"US","date":"2025-03-27","symbol":"SHPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1743048000000,"reportTimeType":"","actualEps":null},{"date":"2024-09-19","symbol":"SHPMY","amount":0.0562,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-09-19","defaultRemindTime":1726752600000,"name":"上海医药ADR","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-11-12","payableDate":"2024-09-19","currency":"USD","dateTimestamp":1726718400000,"payDate":"2024-11-12"},{"market":"US","date":"2024-08-26","symbol":"SHPMY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1724644800000,"reportTimeType":"","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SHPMY\",market:\"US\",,,undefined,":[{"executeDate":"2016-07-13","recordDate":"2016-07-15","paymentDate":"2016-09-12","value":0.198416,"currency":"USD"},{"executeDate":"2019-07-11","recordDate":"2019-07-12","paymentDate":"2019-09-09","value":0.237205,"currency":"USD"},{"executeDate":"2020-07-15","recordDate":"2020-07-16","paymentDate":"2020-09-08","value":0.245893,"currency":"USD"},{"executeDate":"2021-07-14","recordDate":"2021-07-15","paymentDate":"2021-09-13","value":0.293406,"currency":"USD"},{"executeDate":"2023-07-17","recordDate":"2023-07-18","paymentDate":"2023-09-12","value":0.421212,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SHPMY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5714,"hold":0.2857,"sell":0.1429,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.2857,"analysts":7,"updateTime":1757653200000},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SHPMY\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609461095","title":"上海市經信委：在上海好模型不缺算力，好應用不缺語料，好產品不缺芯片","url":"https://stock-news.laohu8.com/highlight/detail?id=2609461095","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609461095?lang=zh_tw&edition=fundamental","pubTime":"2026-02-07 12:48","pubTimestamp":1770439680,"startTime":"0","endTime":"0","summary":"近期上海多家AI企业上市，上海也提出加速人形机器人等创新产品突破产业规模化发展瓶颈。在上海，好模型不缺算力，好应用不缺语料，好产品不缺芯片。上海拥有全国近10%的算力，运营全国首个语料公共服务平台，推出138款备案大模型，实现多款智算芯片突破。《上海市经信委：在上海好模型不缺算力，好应用不缺语料，好产品不缺芯片》栏目主编：张骏文字编辑：曹飞","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/t/2026-02-07/doc-inhkykzi4217183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SHPMY","BK4588","02607","BK4535","00807","161631","601607","BK4585","159813"],"gpt_icon":0},{"id":"2607707197","title":"上海醫藥：芪苓顆粒獲得臨牀試驗批准通知書","url":"https://stock-news.laohu8.com/highlight/detail?id=2607707197","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607707197?lang=zh_tw&edition=fundamental","pubTime":"2026-01-29 16:20","pubTimestamp":1769674855,"startTime":"0","endTime":"0","summary":"格隆汇1月29日丨上海医药(601607.SH)公布，公司下属正大青春宝药业有限公司（简称“青春宝”）自主研发的“芪苓颗粒”（称“该项目”）收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，芪苓颗粒处方源自杭州市中医院的临床验方。人用经验研究表明本品可缓解患者持续的关节肿痛症状，减少痛风急性发作次数；药效学试验表明本品与降尿酸化学药物联用可增强降尿酸效果，同时具有减轻肾脏病理损伤、保护肾功能的作用。该项目由青春宝自主研发，拥有核心知识产权。截至本公告披露日，该项目已累计投入研发费用约1,142万元人民币。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162135a6bace52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260129162135a6bace52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHPMY"],"gpt_icon":0},{"id":"2605145976","title":"上海醫藥B023細胞注射液臨牀試驗獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2605145976","media":"北京商报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605145976?lang=zh_tw&edition=fundamental","pubTime":"2026-01-20 18:55","pubTimestamp":1768906510,"startTime":"0","endTime":"0","summary":"北京商报讯（记者 王寅浩 宋雨盈）1月20日，上海医药发布公告称，公司下属上海医药集团生物治疗技术有限公司自主研发的“B023细胞注射液”收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，同意开展不可手术的经标准治疗失败的、无有效治疗方式的局部晚期或转移性实体瘤的临床试验。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120185825a440bec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260120185825a440bec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4175","SHPMY"],"gpt_icon":0},{"id":"2601868644","title":"中信建投：腦機接口有望打開萬億市場空間 需發掘國家政策支持和具有真實需求「真腦機」","url":"https://stock-news.laohu8.com/highlight/detail?id=2601868644","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601868644?lang=zh_tw&edition=fundamental","pubTime":"2026-01-06 11:27","pubTimestamp":1767670058,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，中信建投发布研报称，脑机接口升级为十五五产业战略，多重政策强力支持下，产业落地有望提速，建议重视投资机遇。脑机接口是医疗投资也是科技投资，短期来看主要应用于疾病治疗，长期来看若能实现增强人、并与AI和机器人融合，有望打开万亿市场空间。在投资方向选择方面，非侵入式和侵入式脑机接口无优劣之分，但需发掘国家政策支持和具有真实需求的“真脑机”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106113407a6f87063&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260106113407a6f87063&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2242644610.SGD","06160","LU2045819591.USD","BK1583","01099","LU0052750758.USD","LU2125910500.SGD","03347","09926","SHPMY","BK1576","LU0708995583.HKD","02269","BK1161","02359","LU0320764599.SGD","01801","BK1574","06978","LU1046422090.SGD","02607","BK1141","01177","00013"],"gpt_icon":0}],"pageSize":4,"totalPage":4,"pageCount":1,"totalSize":16,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/SHPMY\",params:#limit:6,delay:false,,,undefined,":[]}}